Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 28, 2015 12:57 AM ET

Healthcare Equipment and Supplies

Company Overview of Mevion Medical Systems, Inc.

Company Overview

Mevion Medical Systems, Inc., a medical technology company, engages in the development, sale, and service of proton beam radiation therapy systems for radiation treatment of cancer patients. It offers MEVION S250, a proton radiation therapy device for use in patient imaging, positioning, monitoring, motion management, and clinical workflow. The company markets its product to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers worldwide. It has strategic partnership with RaySearch Laboratories AB to develop advanced treatment planning solutions. The company was formerly kno...

300 Foster Sreet

Littleton, MA 01460

United States

Founded in 2004

165 Employees





Key Executives for Mevion Medical Systems, Inc.

Chief Executive Officer, President and Director
Age: 58
Chief Financial Officer and Vice President
Age: 62
Vice President of Operations
Vice President of Regulatory Affairs & Quality Assurance and Administration
Compensation as of Fiscal Year 2014.

Mevion Medical Systems, Inc. Key Developments

Mevion Medical Systems and Philips Radiation Oncology Systems Collaborate to Offer Advanced Treatment planning Solutions for Mevion’s New Pencil Beam Scanning Technology

Mevion Medical Systems and Philips Radiation Oncology Systems are collaborating to combine the treatment planning capability of Philips’ Pinnacle³ radiation therapy planning system with the MEVION S250 solution with HYPERSCAN, Mevion’s new pencil beam scanning technology that is capable of scanning a tumor in seconds. Pinnacle currently supports the MEVION S250, the world’s smallest proton therapy platform. The new collaboration will focus on enabling the Pinnacle³ system to also support HYPERSCAN. The first site to use Pinnacle with the MEVION S250 is the UF Health Cancer Center at Orlando Health. HYPERSCAN has not been cleared by the USFDA for clinical use.

Mevion Medical Systems, Inc. and RaySearch Laboratories AB Announces Strategic Partnership to Develop Advanced Treatment Planning Solutions for the MEVION S250 with Hyperscan

Mevion Medical Systems Inc. and RaySearch Laboratories AB are announcing a partnership to develop advanced treatment planning solutions for the MEVION S250 proton therapy platform. RaySearch's RayStation(R) treatment planning system supports the MEVION S250's current configuration so this new partnership will focus on validating the use of the RayStation treatment planning system for Mevion's new HYPERSCAN pencil beam scanning technology, and developing advanced planning solutions that take advantage of HYPERSCAN's rapid pencil beam delivery capabilities. Mevion and RaySearch are partnering to provide treatment planning systems for the MEVION S250 with HYPERSCAN technology. The partnership is being announced at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), held September 14 - 16 in San Francisco. HYPERSCAN's patented technology, paired with the direct and efficient proton beam generation of the MEVION S250 platform, allows tumor volumes to be quickly scanned in a matter of seconds. This speed makes HYPERSCAN's treatment delivery much less sensitive to patient and tumor motion.

Mevion Medical Systems Introduces HYPERSCAN for the MEVION S250 Platform

Mevion Medical Systems introduced HYPERSCAN for the MEVION S250, the only modular, single room proton therapy system. Benefiting from direct and efficient proton beam generation, HYPERSCAN's patented technology allows radiation to be precisely delivered using a sharp beam of radiation, with the tumor being volumetrically scanned in a matter of seconds. Current pencil beam delivery systems are known to be sensitive to motion which can result in higher treatment uncertainties. HYPERSCAN's fast beam delivery is much less sensitive to patient and tumor motions, thus delivering a more robust treatment. HYPERSCAN is debuting at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), held September 14 -- 16 in San Francisco. Mevion representatives will formally introduce HYPERSCAN at booth 728 in the exhibit hall. HYPERSCAN is built on the MEVION S250 proton therapy platform that has been operating clinically since December 2013. The HYPERSCAN system features rapid volumetric and layer rescanning, a streamlined image-based clinical workflow, sub-millimeter position tracking, and beam gating connectivity. Simultaneously, Mevion is announcing it has reached an agreement with a financial services provider to offer financing to customers interested in purchasing the MEVION S250. This will provide Mevion's customers with an alternative to traditional financing structures, should they desire it.

Similar Private Companies By Industry

Company Name Region
Match Eyewear, LLC United States
Advanced Veterinary Technologies, Inc. United States
VueSonix Sensors, Inc. United States
Eye Care Express Lab Inc. United States
HEMONIX, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mevion Medical Systems, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at